Carvedilol

adrenoceptor beta 2 ; Homo sapiens







18 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 34580163 Unique Positive Cooperativity Between the β-Arrestin-Biased β-Blocker Carvedilol and a Small Molecule Positive Allosteric Modulator of the β2-Adrenergic Receptor. 2021 Nov 1
2 34862306 Correction to "Unique Positive Cooperativity Between the β-Arrestin-Biased β-Blocker Carvedilol and a Small Molecule Positive Allosteric Modulator of the β2-Adrenergic Receptor". 2021 Dec 1
3 26566905 Carvedilol binding to β2-adrenergic receptors inhibits CFTR-dependent anion secretion in airway epithelial cells. 2016 Jan 1 1
4 27090587 Single-molecule imaging reveals the stoichiometry change of β2-adrenergic receptors by a pharmacological biased ligand. 2016 Jun 4 1
5 24668024 Carvedilol induces greater control of β2- than β 1-adrenoceptor-mediated inotropic and lusitropic effects by PDE3, while PDE4 has no effect in human failing myocardium. 2014 Jul 3
6 22760495 Effect of specific ADRB1/ADRB2/AGT genotype combinations on the association between survival and carvedilol treatment in chronic heart failure: a substudy of the ECHOS trial. 2012 Oct 1
7 23166351 MARCH2 promotes endocytosis and lysosomal sorting of carvedilol-bound β(2)-adrenergic receptors. 2012 Nov 26 3
8 21395649 Association of beta-adrenergic receptor polymorphisms and mortality in carvedilol-treated chronic heart-failure patients. 2011 Apr 1
9 21599570 Carvedilol pharmacokinetics and pharmacodynamics in relation to CYP2D6 and ADRB pharmacogenetics. 2011 Jun 2
10 19034036 The beta2 adrenergic receptor Gln27Glu polymorphism affects insulin resistance in patients with heart failure: possible modulation by choice of beta blocker. 2008 Dec 1
11 17383596 Carvedilol, a nonselective beta-blocker, suppresses the production of tumor necrosis factor and tissue factor by inhibiting early growth response factor-1 expression in human monocytes in vitro. 2007 Apr 1
12 17925438 A unique mechanism of beta-blocker action: carvedilol stimulates beta-arrestin signaling. 2007 Oct 16 1
13 16913822 Metabolic effects of beta-adrenoceptor antagonists with special emphasis on carvedilol. 2006 1
14 15057133 Carvedilol: a new candidate for reversal of MDR1/P-glycoprotein-mediated multidrug resistance. 2004 Apr 1
15 15306222 Carvedilol selectively inhibits oscillatory intracellular calcium changes evoked by human alpha1D- and alpha1B-adrenergic receptors. 2004 Sep 1 1
16 12835612 Beta-adrenoceptor genotype influences the response to carvedilol in patients with congestive heart failure. 2003 Jul 3
17 12360591 [Carvedilol in treating primary pulmonary hypertension patients: effect on severity of cardiac failure, degree of pulmonary hypertension, concentration of catecholamines in blood plasma and dependence of cyclic AMP synthesis in lymphocytes on beta-adrenergic receptors]. 2002 1
18 12398570 Nightmares and panic disorder associated with carvedilol overdose. 2002 Nov 4